NCT00984386View on ClinicalTrials.gov

Investigation of the Efficacy of Zesteem in Accelerating Early Wound Healing

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
CicatrixWound-healing
Interventions
DRUG

Zesteem

Intradermal Zesteem, 0.02μg/100μl administered once before punch biopsy

DRUG

Zesteem

Intradermal Zesteem, 0.1μg/100μl administered once before punch biopsy

DRUG

Zesteem

Intradermal Zesteem, 0.2μg/100μl administered once before punch biopsy

DRUG

Zesteem

Intradermal Zesteem, 0.4μg/100μl administered once before punch biopsy

DRUG

Placebo

Intradermal placebo, 100μl administered once before punch biopsy

Trial Locations (1)

M13 9XX

Renovo Clinical Trials Unit, Manchester

All Listed Sponsors
lead

Renovo

INDUSTRY

NCT00984386 - Investigation of the Efficacy of Zesteem in Accelerating Early Wound Healing | Biotech Hunter | Biotech Hunter